S. B. Malkowicz

TL;DR: The validated stratification of PSA outcome after RP using the percentage of positive prostate biopsies in intermediate-risk patients is clinically significant and can be used to identify men with newly diagnosed and clinically localized prostate cancer who are at high risk for early PSA failure and, therefore, may benefit from the use of adjuvant therapy.

TL;DR: In this article, the toxicity and efficacy of an outpatient regimen of paclitaxel plus carboplatin in patients with advanced carcinoma of the urothelium was evaluated.

TL;DR: Toremifene significantly increased hip and spine bone mineral density in men receiving androgen deprivation therapy for prostate cancer and the effect of toremifene on the fracture risk was assessed in the ongoing randomized, controlled trial.

TL;DR: The results suggest that the A49T mutation may influence the pathological characteristics of prostate cancers and, thus, may affect the prognosis of these patients.

TL;DR: The group at the University of Pennsylvania has performed extensive studies that demonstrate the feasibility of interstitial PDT for prostate cancer and their preclinical and clinical experience is herein detailed.